Vérièpe-Salerno, Julie
Cancela, José Antonio
Vischer, Solange
Turzi, Antoine
Cuendet, Muriel
Giannopoulou, Catherine
Berndt, Sarah
Article History
Received: 24 October 2025
Accepted: 29 January 2026
First Online: 9 February 2026
Declarations
:
: The authors declare the following competing interest: S.B. is head project manager, cell therapy, at Regen Lab; an employee of ouis employed by and A.T. is the CEO of Regen Lab SA. The authors receive salary from Regen Lab SA. The study received financial support, materials and reagents from Regen Lab SA. Regen Lab SA develops and commercializes products in the field related to this study and could reasonably benefit from its findings. All other authors declare no competing interests.